Medicenna Therapeutics Corp investor relations material
Listen to the latest call from Medicenna Therapeutics Corp
Medicenna Therapeutics Corp. is a clinical stage immunotherapy company engaged in the development and commercialization of superkines for the treatment of cancer and other diseases. Medicenna Therapeutics Corp., was founded in 2015 and is headquartered in Toronto, Canada.
Ticker
MDNACountry
CAAbout
IR-page